MabswitchMabswitch
  • Home
  • News
  • Technology
  • Pipeline
  • Company
    • About Us
    • Partners and Investors
    • Careers

News

Meetings

Meet us at PEGS Europe in Barcelona

Mabswitch CEO Dr. Onakunle will be presenting in the Antibody-Based Cancer Therapies track, discussing groundbreaking advancements in Remote Controlled Antibodies (TUE Nov 5th, 14:20). We’re proud to be part of this inspiring gathering, pushing forward the boundaries of cancer treatment.

By Mabswitch, 6 monthsNovember 1, 2024 ago
News

Mabswitch wins Golden Ticket supported by Amgen

Mabswitch wins GoldenTicket supported by Abbvie

By Mabswitch, 1 yearApril 30, 2024 ago
News

Mabswitch wins Best Breakthrough Award

At a Pitch Day competition in Los Angeles hosted by GeneOnline US in collaboration with the Taiwan Biomedical Innovation Association (TiBIA), aimed at discovering transformative start-ups that could revolutionize the field, Mabswitch Inc. was awarded the “Best Breakthrough Award“. The Read more…

By Mabswitch, 1 yearApril 11, 2024 ago
Meetings

Meet our CEO at Festival of Biologics in San Diego

Meet Mabswitch CEO and Co-founder Dr. Yemi Onakunle at our booth in the Start-Up Zone at the Festival of Biologics in San Diego in April. Learn about the newest developments on switchable antibody technology, as we also present a poster Read more…

By Mabswitch, 1 yearMarch 28, 2024 ago
News

Mabswitch wins BIO Europe Startup Spotlight 2024

Barcelona, March 19, 2024 – Mabswitch was selected out of several biotech start-up companies to be part of the 8 finalists pitching at the StartUP Spotlight taking place during BIO Europe Spring 2024 in Barcelona,  and emerged as the winner Read more…

By Mabswitch, 1 yearMarch 20, 2024 ago
News

Mabswitch Receives Prestigious SBIR Award from National Institute of Health for LentiSAFE™ Affinity Purification Ligands

Los Angeles, CA – Mabswitch Inc, a pioneering biotechnology company at the forefront of cutting-edge bioprocess technologies, is proud to announce that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 grant by the National Center for Read more…

By Mabswitch, 1 year ago
News

Mabswitch Receives Prestigious SBIR Phase 1 Award from National Cancer Institute for Innovative SaefCAR Immunotherapy Project

Los Angeles, CA – Mabswitch Inc, a pioneering biotechnology company at the forefront of cutting-edge cancer immunotherapies, is proud to announce that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 grant by the National Cancer Institute Read more…

By Mabswitch, 2 yearsSeptember 19, 2023 ago
News

Mabswitch wins Bristol Myers Squibb Golden Ticket Contest

Mabswitch was awarded the Bristol Myers Squibb Golden Ticket. The award provides one year of fully paid individual laboratory bench space and membership at BioLabs@NYULangone, a fully equipped, laboratory-based incubator in Manhattan with facilities, support and equipment designed to accelerate Read more…

By Mabswitch, 2 yearsFebruary 9, 2023 ago
News

Mabswitch wins GoldenTicket supported by Abbvie

The MBC BioLabs Diversity Golden Ticket supported by AbbVie award provides lab space fitted with state-of-the-art research equipment, professional support staff, conference room space for meetings, and a vibrant, collaborative community to share ideas and expertise with other exciting life Read more…

By Mabswitch, 2 yearsDecember 10, 2022 ago
News

MabSwitch is an Awardee of the 2021 CLSA Inspire QuickFire Challenge for Diverse Innovators

MabSwitch™ is an awardee of the 2021 Inspire QuickFire Challenge for Diverse Innovators for its approach to create innovative solutions for patients. The Inspire QuickFire Challenge is a joint program of California Life Sciences Association (CLSA), the trade association representing Read more…

By Mabswitch, 4 yearsNovember 10, 2021 ago
LinkedIn
News
  • Meet us at PEGS Europe in Barcelona
  • Mabswitch wins Golden Ticket supported by Amgen
  • Mabswitch wins Best Breakthrough Award
  • Meet our CEO at Festival of Biologics in San Diego
  • Mabswitch wins BIO Europe Startup Spotlight 2024
  • Mabswitch Receives Prestigious SBIR Award from National Institute of Health for LentiSAFE™ Affinity Purification Ligands
  • Mabswitch Receives Prestigious SBIR Phase 1 Award from National Cancer Institute for Innovative SaefCAR Immunotherapy Project
  • Mabswitch wins Bristol Myers Squibb Golden Ticket Contest
  • Mabswitch wins GoldenTicket supported by Abbvie
  • MabSwitch is an Awardee of the 2021 CLSA Inspire QuickFire Challenge for Diverse Innovators
  • About Us
  • Careers
  • Company
  • Disclaimer
  • News
  • Partners and Investors
  • Pipeline
  • Technology
  • Think Switch
Hestia | Developed by ThemeIsle